Proteomic evaluation of urine from renal cell carcinoma using SELDI-TOF-MS and tree analysis pattern

Technology in Cancer Research and Treatment

Volumn 7, Issue 3, 2008, Pages 155-160

  Wu, Deng Long ^a   Zhang, Wen Hong ^b   Wang, Wen Jing ^c   Jing, San Bao ^a   Xu, Yue Ming ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c Shanghai Municipal Center for Disease Control and Prevention   (China)

Author keywords

Biological markers; Proteome; Renal cell carcinoma; SELDI; Urine

Indexed keywords

BIOLOGICAL MARKER; PROTEIN;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BIOINFORMATICS; COMPUTER PROGRAM; CONTROLLED STUDY; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; PROTEIN MICROARRAY; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TREE ANALYSIS PATTERN; URINALYSIS; UROGENITAL TRACT DISEASE;

EID: 45349089587     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460800700301     Document Type: Article

References (18)

1. Sarto, C., Deon, C., Doro, G., Hochstrasser, D. F., Mocarelli, P., Sanchez, J. C. Contribution of proteomics to the molecular analysis of renal cell carcinoma with an emphasis on manganese superoxide dismutase. Proteomics 1, 1288-1294 (2001).
2. Klade, C. S., Voss, T., Krystek, E., Ahorn, H., Zatloukal, K., Pummer, K., Adolf, G. R. Identification of tumor antigens in renal cell carcinoma by serological proteome analysis. Proteomics 1, 890-898 (2001).
3. Shen, H., Cheng, G., Fan, H., Zhang, J., Zhang, X., Lu, H., Liu, C., Sun, F., Jin, H., Xu, X., Xu, G., Wang, S., Fang, C., Bao, H., Wang, Y., Wang, J., Zhong, H., Yu, Z., Liu, Y., Tang, Z., Yang, P. Expressed proteome analysis of human hepatocellular carcinoma in nude mice (LCI-D20) with high metastasis potential. Proteomics 6, 528-537 (2006)
4. Lee, I. N., Chen, C. H., Sheu, J. C., Lee, H. S., Huang, G. T., Yu, C. Y., Lu, F. J., Chow, L. P. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry. J Proteome Res 4, 2062-2069 (2005).
5. Ornstein, D. K., Tyson, D. R. Proteomics for the identification of new prostate cancer biomarkers. Urol Oncol 24, 231-236 (2006).
6. Li, J., Zhao, J., Yu, X., Kuerer, H., Krishnamurthy, S., Schilling, E., Khan, S. A., Sukumar, S., Chan, D. W. Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid. Clin Cancer Res 11, 8312-8320 (2005).
7. Vlahou, A., Schellhammer, P. F., Mendrinos, S., Patel, K., Kondylis, F. I., Gong, L., Nasim, S., Wright, G. L. Jr. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am J Pathol 158, 1491-1502 (2001).
8. Zhang, Y. F., Wu, D. L., Guan, M., Liu, W. W., Wu, Z., Chen, Y. M., Zhang, W. Z., Lu, Y. Tree analysis of mass spectral urine profiles discriminates transitional cell carcinoma of the bladder from noncancer patient. Clin Biochem 37, 772-779 (2004).
9. Wang, L., Zhu, Y. F., Guo, X. J., Huo, R., Ma, X., Lin, M., Zhou, Z. M., Sha, J. H. A two-dimensional electrophoresis reference map of human ovary. J Mol Med 83, 812-821 (2005).
10. Zhou, G., Li, .H, Gong, Y., Zhao, Y., Cheng, J., Lee, P., Zhao, Y. Proteomic analysis of global alteration of protein expression in squamous cell carcinoma of the esophagus. Proteomics 5, 3814-3821 (2005).
11. von Eggeling, F., Junker, K., Fiedle, W., Wollscheid, V., Dürst, M., Claussen, U., Ernst, G. Mass spectrometry meets chip technology: a new proteomic tool in cancer research? Electrophoresis 22, 2898-2902 (2001).
12. Junker, K., Gneist, J., Melle, C., Driesch, D., Schubert, J., Claussen, U., Von Eggeling, F. Identification of protein pattern in kidney cancer using ProteinChip arrays and bioinformatics. Int J MlI Med 15, 285-290 (2005).
13. Tolson, J., Bogumil, R., Brunst, E., Beck, H., Elsner, R., Humeny, A., Kratzin, H., Deeg, M., Kuczyk, M., Mueller, G. A., Mueller, C. A., Flad, T. Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients. Lab Invest 84, 845-856 (2004)
14. Won, Y., Song, H. J., Kang, T. W., Kim, J. J., Han, B. D., Lee, S. W. Pattern analysis of serum proteome distinguishes renal cell carcinoma from other urologic diseases and healthy persons. Proteomics 3, 2310-2316 (2003).
15. Streckfus, C. F., Bigler, L. R., Zwick, M. The use of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to detect putative breast cancer markers in saliva: a feasibility study. J Oral Pathol Med 35, 292-300 (2006).
16. Zhuang, Z., Huang, S., Kowalak, J. A., Shi, Y., Lei, J., Furuta, M., Lee, Y. S., Lubensky, I. A., Rodgers, G. P., Cornelius, A. S., Weil, R. J., Teh, B. T., Vortmeyer, A. O. From tissue phenotype to proteotype: sensitive protein identification in microdissected tumor tissue. Int J Oncol 28, 103-110 (2006).
17. Rogers, M. A., Clarke, P., Noble, J., Munro, N. P., Paul, A., Selby, P. J., Banks, R. E. Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis identification of key issues affecting potential clinical utility. Cancer Res 63, 6971-6983 (2003).
18. Young, A. N., De Oliveira Salles, P. G., Lim, S. D., Cohen, C., Petros, J. A., Marshall, F. F., Neish, A. S., Amin, M. B. β defensin-1, par-albumin and vimentin: a panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cDNA microarrays. Am J Surg Pathol 27, 199-205 (2003).